Business Context and Reporting Period
This Form 8-K filing by The Bank of New York Mellon Corporation (BNY Mellon) was submitted on December 10, 2018. The report details a corporate action regarding the repurchase of the company's common stock, approved by both the Board of Directors and the Federal Reserve.
Key Financial Metrics
This filing does not contain standard financial performance metrics such as revenue, profit, cash flow, margins, or debt levels. The primary financial figure disclosed relates to capital allocation:
- New Share Repurchase Authorization: Up to $830 million.
- Previous Authorization (June 2018): $2.4 billion.
- Total Available Authorization: $3.23 billion (cumulative).
Material Changes
The material change reported is the expansion of the company's share repurchase program. The Board of Directors approved an additional $830 million in repurchases, effective immediately. This authorization is in addition to the $2.4 billion program announced on June 28, 2018. The Federal Reserve also approved this additional repurchase amount.
Guidance, Outlook, and Risks
Program Details: The repurchases are scheduled to continue through the second quarter of 2019. Execution methods may include open market purchases, privately negotiated transactions, Rule 10b5-1 plans, and structured transactions such as accelerated share repurchases.
Risks and Forward-Looking Statements: The filing includes standard disclaimers regarding forward-looking statements. Actual outcomes may differ due to risks and uncertainties outlined in the company's 2017 Form 10-K and the Form 10-Q for the period ended September 30, 2018. The company undertakes no obligation to update this information.
Investor Verification Checklist
- Verify the total remaining balance of the $2.4 billion repurchase program announced in June 2018 to calculate the total remaining buyback capacity.
- Review the company's most recent Form 10-Q (ended September 30, 2018) for liquidity and capital adequacy metrics supporting this buyback.
- Monitor subsequent filings for the actual execution rate of the new $830 million authorization.
- Confirm any regulatory conditions attached to the Federal Reserve's approval of the repurchase.